ICF: UK Brain BioLink (UK Brain Biology Resource Link)

MRC · United Kingdom government procurement

Closed September 29, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Brain BioLink is an initiative that will connect NHS patients and participants in longitudinal research projects with researchers that study the composition and function of nervous system tissue. The purpose of Brain BioLink is to aid understanding of what participation in tissue-based research entails, and allow volunteers to keep track of their choices and learn about neurosciences research. Further, Brain BioLink will allow researchers to share tissue samples and pool resources. This will ensure valuable samples get maximum use for maximum scientific benefit. Brain BioLink will also test new ways of analysing tissue samples for diagnostics and quality control. The aim of Brain BioLink is to improve UK neuroscience research for individual and societal benefit

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
ClosedSeptember 29, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Dectin-1-mediated suppression of protective anti-mycobacterial immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.